Target intelligence / Profile preview

E3 ubiquitin-protein ligase PHF7 (PHF7)

Target
PHF7
Molecular classification
Enzyme, E3 ubiquitin ligase, Epigenetic writer, PHD finger protein
01

Overview

E3 ubiquitin-protein ligase PHF7 (PHF7) is a multidomain protein containing extended plant homeodomain (ePHD) and RING finger domains, acting as a RING-type E3 ubiquitin ligase. PHF7 is specifically and predominantly expressed in the male germline, where it is essential for proper progression of spermatogenesis and male fertility. PHF7's domains cooperate for substrate recognition and catalytic activity: the ePHD recognizes nucleosomal DNA, while its PHD domain binds to methylated lysine 4 of histone H3 (H3K4me2/3), acting as an epigenetic reader, and the RING domain confers E3 ubiquitin ligase activity, specifically targeting lysine 14 of histone H3 and histone H2A for ubiquitination. These modifications facilitate the critical histone-to-protamine exchange necessary for maturation of elongating spermatids. Loss of PHF7 impairs histone removal, resulting in male infertility due to defective chromatin remodeling. PHF7 additionally appears to promote and induce male germline identity and is involved in epigenetic regulation by coordinating histone binding and ubiquitination[1][2][3][4][5]. There are currently no drugs or clinical biomarkers linked to PHF7; its role is of scientific interest as a fundamental regulator of spermatogenesis and epigenetic reprogramming, but it is not considered a therapeutic target in current literature.

Other names
PHF7PHD finger protein 7E3 ubiquitin-protein ligase PHF7NYD-SP6HSPC226HSPC045testicular secretory protein Li 34testis development protein NYD-SP6
02

Biological functions

Histone ubiquitination (specifically histones H2A and H3)Histone-to-protamine exchangeRegulation of spermatogenesisMaintenance of male germ cell identityChromatin association/epigenetic regulation
03

Disease associations

Male infertilityDefects in spermatogenesisOther (no strong evidence for cancer or other specific diseases)

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase PHF7 (PHF7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase PHF7 (PHF7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call